| The contribution of the blood glutamate scavenging activity of pyruvate to its neuroprotective properties in a rat model of closed head injury A Zlotnik, B Gurevich, E Cherniavsky, S Tkachov, A Matuzani-Ruban, ... Neurochemical research 33, 1044-1050, 2008 | 83 | 2008 |
| β-arrestin-1 levels: reduced in leukocytes of patients with depression and elevated by antidepressants in rat brain S Avissar, A Matuzany-Ruban, K Tzukert, G Schreiber American Journal of Psychiatry 161 (11), 2066-2072, 2004 | 71 | 2004 |
| Human recombinant glutamate oxaloacetate transaminase 1 (GOT1) supplemented with oxaloacetate induces a protective effect after cerebral ischemia M Pérez-Mato, P Ramos-Cabrer, T Sobrino, M Blanco, A Ruban, ... Cell death & disease 5 (1), e992-e992, 2014 | 68 | 2014 |
| Long term follow‐up of dental implants placed in autologous onlay bone graft D Schwartz‐Arad, R Ofec, G Eliyahu, A Ruban, N Sterer Clinical implant dentistry and related research 18 (3), 449-461, 2016 | 62 | 2016 |
| Blood glutamate scavengers prolong the survival of rats and mice with brain-implanted gliomas A Ruban, T Berkutzki, I Cooper, B Mohar, VI Teichberg Investigational new drugs 30, 2226-2235, 2012 | 55 | 2012 |
| Oxaloacetate restores the long-term potentiation impaired in rat hippocampus CA1 region by 2-vessel occlusion M Marosi, J Fuzik, D Nagy, G Rákos, Z Kis, L Vécsei, J Toldi, ... European journal of pharmacology 604 (1-3), 51-57, 2009 | 41 | 2009 |
| Combined treatment of an amyotrophic lateral sclerosis rat model with recombinant GOT1 and oxaloacetic acid: a novel neuroprotective treatment A Ruban, K Cohen-Kashi Malina, I Cooper, N Graubardt, L Babakin, ... Neurodegenerative diseases 15 (4), 233-242, 2015 | 40 | 2015 |
| Differences in mental health and health-related quality of life between the Israeli and Italian population during a COVID-19 quarantine A Amit Aharon, I Dubovi, A Ruban Quality of Life Research 30, 1675-1684, 2021 | 37 | 2021 |
| Dynamics of beta-arrestin1 protein and mRNA levels elevation by antidepressants in mononuclear leukocytes of patients with depression A Matuzany-Ruban, S Avissar, G Schreiber Journal of affective disorders 88 (3), 307-312, 2005 | 37 | 2005 |
| Knowledge and information credibility evaluation strategies regarding COVID-19: A cross-sectional study AA Aharon, A Ruban, I Dubovi Nursing Outlook 69 (1), 22-31, 2021 | 35 | 2021 |
| Mesenchymal stem cells derived extracellular vesicles improve behavioral and biochemical deficits in a phencyclidine model of schizophrenia H Tsivion-Visbord, N Perets, T Sofer, L Bikovski, Y Goldshmit, A Ruban, ... Translational psychiatry 10 (1), 305, 2020 | 33 | 2020 |
| Regenerating the Injured Spinal Cord at the Chronic Phase by Engineered iPSCs‐Derived 3D Neuronal Networks L Wertheim, R Edri, Y Goldshmit, T Kagan, N Noor, A Ruban, A Shapira, ... Advanced Science 9 (11), 2105694, 2022 | 31 | 2022 |
| Blood glutamate scavenging as a novel neuroprotective treatment for paraoxon intoxication A Ruban, B Mohar, G Jona, VI Teichberg Journal of Cerebral Blood Flow & Metabolism 34 (2), 221-227, 2014 | 31 | 2014 |
| Liver enzymes and risk of stroke: the atherosclerosis risk in communities (ARIC) study A Ruban, N Daya, ALC Schneider, R Gottesman, E Selvin, J Coresh, ... Journal of stroke 22 (3), 357, 2020 | 24 | 2020 |
| Blood glutamate scavenger as a novel neuroprotective treatment in spinal cord injury Y Goldshmit, G Jona, E Schmukler, S Solomon, R Pinkas-Kramarski, ... Journal of neurotrauma 35 (21), 2581-2590, 2018 | 24 | 2018 |
| Normalization of GRK2 protein and mRNA measures in patients with depression predict response to antidepressants A Matuzany-Ruban, M Golan, N Miroshnik, G Schreiber, S Avissar International Journal of Neuropsychopharmacology 13 (1), 83-91, 2010 | 20 | 2010 |
| Blood glutamate scavengers and exercises as an effective neuroprotective treatment in mice with spinal cord injury Y Goldshmit, E Banyas, N Bens, A Yakovchuk, A Ruban Journal of Neurosurgery: Spine 33 (5), 692-704, 2020 | 19 | 2020 |
| Methods of treating cancer of the central nervous system VI Teichberg, A Ruban-Matuzani US Patent 9,034,319, 2015 | 15 | 2015 |
| MRS of brain metabolite levels demonstrates the ability of scavenging of excess brain glutamate to protect against nerve agent induced seizures A Ruban, IE Biton, A Markovich, D Mirelman International Journal of Molecular Sciences 16 (2), 3226-3236, 2015 | 15 | 2015 |
| Behavioral aspects and neurobiological properties underlying medical cannabis treatment in Shank3 mouse model of autism spectrum disorder S Poleg, E Kourieh, A Ruban, G Shapira, N Shomron, B Barak, D Offen Translational Psychiatry 11 (1), 524, 2021 | 12 | 2021 |
